• Purification, characterization and plasma half-life of PEGylated soluble recombinant non-HA-binding CD44Pink, Anne; Kallastu, Aili; Turkina, Marina; Školnaja, Marianna; Kogerman, Priit; Päll, Taavi; Valkna, AndresBioDrugs2014 / p. 393-402 : ill https://doi.org/10.1007/s40259-014-0089-y https://www.scopus.com/sourceid/20051 https://www.scopus.com/record/display.uri?eid=2-s2.0-84904856792&origin=inward&txGid=671b281b4a4509bf5328585fbf2a1508 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=BIODRUGS&year=2014 https://www.webofscience.com/wos/woscc/full-record/WOS:000344602700007
• Soluble CD44 interacts with intermediate filament protein vimentin via its hyaluronic acid-binding domainPink, Anne; Päll, Taavi; Kasak, Lagle; Linno, Anne Mari; Turkina, Marina; Anderson, Wally; Valkna, Andres; Kogerman, PriitSpetsai Summer School : Protein and their Networks-from specific to global analysis : Spetses, Greece, 7.09.2009-17.09.20092009 / ? p https://www.researchgate.net/publication/51981634_Soluble_CD44_Interacts_with_Intermediate_Filament_Protein_Vimentin_on_Endothelial_Cell_Surface
• Studies of CD44 hyaluronan binding domain as novel angiogenesis inhibitor = CD44 hüaluroonhapet siduv domään kui uudne angiogeneesi inhibiitorPäll, Taavi2013 https://www.ester.ee/record=b2992362*est